Bisphosphonate-related osteonecrosis of the jaw: specificities
Author(s) -
Siri Paulo,
Ana Margarida Abrantes,
Mafalda Laranjo,
Lina Carvalho,
Arménio C. Serra,
Maria Filomena Botelho,
Manuel Marques Ferreira
Publication year - 2014
Publication title -
oncology reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.637
H-Index - 21
eISSN - 1970-5565
pISSN - 1970-5557
DOI - 10.4081/oncol.2014.254
Subject(s) - medicine , osteonecrosis of the jaw , bisphosphonate , complication , bisphosphonate associated osteonecrosis of the jaw , pathological , soft tissue , dentistry , jaw bone , osteoporosis , pathology , surgery , implant
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe complication that has recently emerged in patients treated with intravenous bisphosphonates for malignant diseases. This complication usually presents after a minor local trauma during a dental treatment. Several etiopathogenic mechanisms of this pathological condition have been proposed, but no model can explain all morphological changes observed at the macroscopic and microscopic level. BRONJ is likely to be related to direct toxicity in the bone and soft tissue cells, due to nitrogen-containing bisphosphonates. This review elucidates the clinical indications and mechanism of action of bisphosphonates, reports some clinical diagnostic criteria for BRONJ, describe the histopathological criteria for BRONJ diagnosis, the potential triggering pathways and the available treatment strategies
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom